Literature DB >> 5684392

The effect of neuroleptic drug treatment on plasma fibrinogen concentrations in schizophrenic states.

C J Brackenridge, I H Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5684392      PMCID: PMC496369          DOI: 10.1136/jnnp.31.4.326

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

1.  A human plasma factor inducing behavioral and electro-physiological changes in animals. II. Changes induced in animals.

Authors:  J R BERGEN; W P KOELLA; H FREEMAN; H HOAGLAND
Journal:  Ann N Y Acad Sci       Date:  1962-01-13       Impact factor: 5.691

2.  Blood proteins in functional psychoses. A review of the literature and unifying hypothesis.

Authors:  W J FESSEL
Journal:  Arch Gen Psychiatry       Date:  1962-02

3.  Long-term study of chlorpromazine and meprobamate on serum protein profile.

Authors:  M J CARVER
Journal:  J Nerv Ment Dis       Date:  1962-08       Impact factor: 2.254

4.  Serum oxidase tests and schizophrenia.

Authors:  A YUWILER; I M JENKINS; A DUKAY
Journal:  Arch Gen Psychiatry       Date:  1961-04

5.  Fibrinogen changes in relation to cerebrovascular accidents.

Authors:  F A ELLIOTT; M BUCKELL
Journal:  Neurology       Date:  1961-02       Impact factor: 9.910

6.  The protein profile in chlorpromazine therapy.

Authors:  G TRIGOS; W MCCULLOUGH
Journal:  Dis Nerv Syst       Date:  1955-10

7.  Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques.

Authors:  R G Heath; I M Krupp
Journal:  Arch Gen Psychiatry       Date:  1967-01

8.  Schizophrenia as an immunologic disorder. II. Effects of serum protein fractions on brain function.

Authors:  R G Heath; I M Krupp; L W Byers; J I Liljekvist
Journal:  Arch Gen Psychiatry       Date:  1967-01

9.  The relationship between dextran precipitable fibrinogen and 170H corticosteroid levels in psychotic subjects.

Authors:  I A Cameron; J Dawson
Journal:  J Psychosom Res       Date:  1967-08       Impact factor: 3.006

10.  Hyperfibrinogenemia in schizophrenia.

Authors:  U S Seal; W R Swaim; H Eist
Journal:  Clin Chem       Date:  1967-02       Impact factor: 8.327

View more
  1 in total

1.  Relation of hypermagnesaemia to activity and neuroleptic drug therapy in schizophrenic states.

Authors:  C J Brackenridge; I H Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-04       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.